Elevations in the tumor marker, squamous cell carcinoma antigen (SCCA), were associated with increased MACE risk, while elevations in neuron‐specific enolase (NSE) were associated with increased malignancy risk (Table S2). This evidence concerns the gene ENO2 and neoplasm.